Skip to main content
SpringerLink
Log in

Mechanisms of Estrogen Action on the Cardiovascular System

  • Conference paper
Hormonal Carcinogenesis III

  • 92 Accesses

Abstract

Population studies have repeatedly shown a beneficial effect of postmenopausal estrogen (E) use on coronary heart disease (CHD) (1), with an overall reduction of around 50% in the incidence. Prospective randomized controlled clinical trials are now under way to confirm these epidemiological findings (2). However, it is clearly important to understand the biological basis of these actions of E on the cardiovascular (CV) system in order to optimize current hormone replacement therapies (HRT) and develop new HRT with maximum CV impact for the future.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stampfer MJ, Grodstein F (1994) Role of hormone replacement in cardiovascular disease. In: Lobo RA (ed) Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. Raven Press Ltd, New York, pp. 223–233.

    Google Scholar 

  2. Spencer CP, Cooper AJ, Stevenson JC (1996) Clinical trials in progress with hormone replacement therapy. Exp Opin Invest Drugs 5:739–749.

    Article  CAS  Google Scholar 

  3. Bengtsson C, Björkelund C, Lapidus L et al. (1993) Associations of serum lipid concentrations and obesity with mortality in women: 20 year follow up of participants in prospective population study in Gothenburg, Sweden. Br Med J 307:1385–1388.

    Article  CAS  Google Scholar 

  4. Whitcroft SI, Crook D, Marsh MS et al. (1994) Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations. Obstet Gynecol 84:222–226.

    PubMed  CAS  Google Scholar 

  5. van der Mooren MJ, de Graaf J, Demacker PN et al. (1994) Changes in the low-density lipoprotein profile during 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women. Metabolism 43:799–802.

    Article  PubMed  Google Scholar 

  6. Campos H, Walsh B W, Judge H et al. (1997) Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab 82:3955–3963.

    Article  PubMed  CAS  Google Scholar 

  7. Sack MN, Rader DJ, Cannon RO (1994) Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 343:269–270.

    Article  PubMed  CAS  Google Scholar 

  8. Koh KK, Mincemoyer R, Bui MN et al. (1997) Effects of hormone replacement therapy on fibrinolysis in postmenopausal women. N Engl J Med 336:683–690.

    Article  PubMed  CAS  Google Scholar 

  9. Westerveld HT, Kock LAW, van Rijn JM et al. (1995) 17ß-estradiol improves postprandial lipid metabolism in postmenopausal women. J Clin Endocrinol Metab 80:249–253.

    Article  PubMed  CAS  Google Scholar 

  10. Crook D, Cust MP, Gangar KF et al. (1992) Comparison of transdermal and oral estrogen/progestin hormone replacement therapy: effects on serum lipids and lipoproteins. Am J Obstet Gynecol 166:950–955.

    PubMed  CAS  Google Scholar 

  11. Crook D, Godsland IF, Hull J et al. (1997) Hormone replacement therapy with dydrogesterone and 17ß-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up. Br J Obstet Gynaecol 104:298–304.

    Article  PubMed  CAS  Google Scholar 

  12. Stout R (1990) Insulin and atheroma: 20-yr perspective. Diabetes Care 13: 631–654.

    Article  PubMed  CAS  Google Scholar 

  13. Notelovitz M, Johnston M, Smith S et al. (1987) Metabolic and hormonal effects of 25mg and 50mg 17ß estradiol implants in surgically menopausal women. Obstet Gynecol 70:749–754.

    PubMed  CAS  Google Scholar 

  14. Cagnacci A, Soldani R, Carriero P et al. (1992) Effects of low doses of transdermal 17ß-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab 74:1396–1400.

    Article  PubMed  CAS  Google Scholar 

  15. Spellacy WN, Buhi WC, Birk SA (1972) The effects of estrogens on carbohydrate metabolism: glucose, insulin and growth hormone studies on one hundred and seventy one women ingesting Premarin, mestranol and ethinyl estradiol for six months. Am J Obstet Gynecol 114:378–392.

    PubMed  CAS  Google Scholar 

  16. Godsland IF, Gangar KF, Walton C et al. (1993) Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 42:846–853.

    Article  PubMed  CAS  Google Scholar 

  17. Winkler UH (1992) Menopause, hormone replacement therapy and cardiovascular disease: a review of haemostaseological findings. Fibrinolysis 6 suppl 3:5–10.

    Article  Google Scholar 

  18. Paganini-Hill A, Ross RK, Henderson BE (1988) Postmenopausal oestrogen treatment and stroke: a prospective study. Br Med J 297:519–522.

    Article  CAS  Google Scholar 

  19. Scarabin P-Y, Alhenc-Gelas M, Plu-Bureau G (1997) Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. Arterioscler Thromb Vase Biol 17: 3071–3078.

    Article  CAS  Google Scholar 

  20. Fox J, George AJ, Newton JR et al. (1993) Effect of transdermal oestradiol on the haemostatic balance of menopausal women. Maturitas 18:55–64.

    Article  PubMed  CAS  Google Scholar 

  21. Magness RR, Rosenfeld CR (1989) Local and systemic estradiol-17 beta: effects on uterine and systemic vasodilation. Am J Physiol 256:E536–E542.

    PubMed  CAS  Google Scholar 

  22. Gangar KF, Vyas S, Whitehead M et al. (1991) Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 338:839–842.

    Article  PubMed  CAS  Google Scholar 

  23. Hillard TC, Bourne TH, Whitehead MI et al. (1992) Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women. Fertility and Sterility 58:959–963.

    PubMed  CAS  Google Scholar 

  24. Rosano GMC, Sarrel PM, Poole-Wilson P et al. (1993) Beneficial effect of oestrogen on exercise-induced myocardial ischemia in women with coronary artery disease. Lancet 342:133–136.

    Article  PubMed  CAS  Google Scholar 

  25. Collins P, Shay J, Jiang C et al. (1994) Nitric oxide accounts for dose- dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation 90:1964–1968.

    PubMed  CAS  Google Scholar 

  26. Wingrove CS, Stevenson JC (1997) 17β-oestradiol inhibits stimulated endothelin release in human vascular endothelial cells. Eur J Endocrinol 137: 205–208.

    Article  PubMed  CAS  Google Scholar 

  27. Williams JK, Adams MR, Klopfenstein HS (1990) Estrogen modulates responses of atherosclerotic coronary arteries. Circulation Res 81:1680–1687.

    Article  CAS  Google Scholar 

  28. Gilligan DM, Badar DM, Panza JA (1994) Acute vascular effects of estrogen in postmenopausal women. Circulation 90:786–791.

    PubMed  CAS  Google Scholar 

  29. Collins P, Rosano GMC, Sarrel PM et al. (1995) 17ß-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 92:24–30.

    PubMed  CAS  Google Scholar 

  30. Jiang C, Poole-Wilson P, Sarrel P et al. (1992) Effects of 17β -oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol 106:739–745.

    PubMed  CAS  Google Scholar 

  31. White RE, Darkow DJ, Falvo Lang JL (1995) Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism. Circ Res 77:936–942.

    PubMed  CAS  Google Scholar 

  32. Buikema H, Pinto YM, Rooks G et al. (1996) The deletion polymorphism of the anfiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J 17:787–794.

    PubMed  CAS  Google Scholar 

  33. Schuster H, Wienker TF, Stremmler U et al. (1995) An angiotensin- converting enzyme gene variant is associated with acute myocardial infarction in women but not in men. Am J Cardiol 76:601–603.

    Article  PubMed  CAS  Google Scholar 

  34. Proudler AJ, Ahmed AIH, Crook D et al. (1995) Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet 346:89–90.

    Article  PubMed  CAS  Google Scholar 

  35. Dollery CM, McEwan JR, Henney AM (1995) Matrix metalloproteinases and cardiovascular disease. Circ Res 77:863–868.

    PubMed  CAS  Google Scholar 

  36. Wingrove CS, Garr E, Godsland IF et al. (1998) 17β-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim Biophys Acta 1406:169–174.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. John C. Stevenson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Etiology & Prevention of Hormonal Cancers Kansas Cancer Intitute, University of Kansas Medical Center, Kansas City, Kansas, 66160, USA

    Jonathan J. Li Ph.D. (Professor of Pharmacology, Toxicology, and Therapeutics Director) & Sara Antonia Li Ph.D. (Associate Professor of Pharmacology, Toxicology, and Therapeutics) (Professor of Pharmacology, Toxicology, and Therapeutics Director) &  (Associate Professor of Pharmacology, Toxicology, and Therapeutics)

  2. Division of Public Health Sciences Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, 98101, USA

    Janet R. Daling Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag New York, Inc.

About this paper

Cite this paper

Stevenson, J.C. (2001). Mechanisms of Estrogen Action on the Cardiovascular System. In: Li, J.J., Li, S.A., Daling, J.R. (eds) Hormonal Carcinogenesis III. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2092-3_36

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2092-3_36

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7411-7

  • Online ISBN: 978-1-4612-2092-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation